Stocktoria

Oaktree Specialty Lending Corp OCSL

Nasdaq · stock · website · IPO 2008-06-12 · LEI

Oaktree Specialty Lending Corp (OCSL) earns a Piotroski F-score of 4/9 (mixed financial health). It pays a dividend yielding 14.39% (safety: at-risk).

Chart by TradingView
44/100
Stocktoria Quality Score · grade C
4/9
Piotroski F — financial health
Altman Z″ — distress risk
11.8%
Dividend yield 5y avg · at-risk · Dividend payout 436.9%

Quality score trend · recomputed for each fiscal year

Piotroski F /9
4 2 4 202320242025

Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.

$12.74 as of 2026-08-01 · -9% 1y
$11.30$14.0052-wk
Market cap USD$1.0B
P / E30.4×
Dividend yield 5y avg11.8%
Beta0.57

Analyst price target

$12.43 -2.4% vs last
· 6 analysts
target range $11.50 – $13.50

Wall Street analyst consensus — a sentiment gauge, not our scoring.

Smart money · insiders, last 12 months

Insiders net bought +$88,059 on the open market · 5 trades

Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.

Piotroski F breakdown · 4/9 tests passed

About Oaktree Specialty Lending Corp

Oaktree Specialty Lending Corporation is a business development company. The fund specializing in investments in middle market, bridge financing, first and second lien debt financing, unsecured and mezzanine loan, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, preferred equity, and management buyouts in small and mid-sized companies. It seeks to invest in education services, business services, retail and consumer, healthcare, manufacturing, food and restaurants, construction and engineering. The firm also seeks investment in media, advertising sectors, software, IT services, pharmaceuticals, biotechnology, real estate management and development, chemicals, machinery, and internet and direct marketing retail sectors. It invests between $5 million to $75 million principally in the form of one-stop, first lien, and second lien debt investments, which may include an equity co-investment component in companies. The firm invest in companies having enterprise value between $20 million and $150 million and EBITDA between $3 million and $50 million. The fund has a hold size of up to $75 million and may underwrite transactions up to $100 million. It primarily invests in North America. The fund seeks to be a lead investor in its portfolio companies.

FAQ

Is OCSL financially healthy?

Oaktree Specialty Lending Corp's Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak).

Does OCSL pay a dividend, and is it safe?

Yes. Oaktree Specialty Lending Corp pays a dividend yielding about 14.39% with a 436.9% payout ratio, rated “at-risk” for safety.

How profitable is OCSL?

In FY2025, Oaktree Specialty Lending Corp had a return on equity of 2.3%.

Is OCSL overvalued or undervalued?

Oaktree Specialty Lending Corp trades at about 32.7× trailing earnings — near its 10-year norm (10-year range 11.7×–41.2×, median 35.7×). Stocktoria reports the data, not buy/sell advice.

What is the analyst price target for OCSL?

The average Wall-Street price target for Oaktree Specialty Lending Corp is $12.43, about 2.4% below the recent price, from 6 analysts.

Is OCSL a good stock to buy?

Stocktoria doesn't give buy or sell advice, but here is the data on Oaktree Specialty Lending Corp: a Piotroski F-score of 4/9, a P/E of about 30.4×, a dividend yield of 14.39%. Weigh these quality and valuation signals against your own goals.

Computed from company filings · US · as of 2025-09-30. Facts plus Stocktoria's own computed scores — not investment advice.